Torben F. H.
- Country
- Denmark
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 71 partner sites.
Specializations
Solid Tumor Oncology
Focuses on therapeutic strategies for a range of malignant solid tumors across multiple organ systems.
- Breast cancer
- Colorectal cancer
- Non‑Small Cell Lung Cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Melanoma
- Head and neck squamous cell carcinoma
Emphasis on targeted agents, immunotherapies and combination regimens.
Hematologic Malignancies
Investigates treatments for blood‑derived cancers and related disorders.
- Chronic lymphocytic leukemia
- Multiple myeloma
- Diffuse large B‑cell lymphoma
- Follicular lymphoma
- Mantle cell lymphoma
- Acute myeloid leukemia
Includes novel antibody‑based therapies and cellular approaches.
Respiratory and Pulmonary Disorders
Addresses chronic and acute lung conditions with a therapeutic orientation.
- Asthma
- Chronic obstructive pulmonary disease
- Pulmonary sarcoidosis
- Bronchiectasis
- Severe viral lung infections
- Nontuberculous mycobacterial lung infection
Focus on biologics, anti‑inflammatory agents and precision medicine.
Cardiovascular and Metabolic Disease
Targets cardiovascular risk reduction and metabolic disease management.
- Atrial fibrillation
- Ischemic stroke
- Acute myocardial infarction
- Type 2 diabetes
- Hypertension
- Atherosclerotic cardiovascular disease
Explores antithrombotic strategies and metabolic modulators.
Renal and Kidney Disease
Concentrates on renal pathologies and associated therapeutic interventions.
- Focal segmental glomerulosclerosis
- Chronic kidney disease
- Diabetic nephropathy
- Hypertensive nephropathy
- Acute interstitial nephritis
Includes studies on renoprotective agents and disease‑modifying therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.